In our experiments using isolated glomerular samples, low- and high-dose ipragliflozin reduced synaptopodin expression and subsequent oxidative stress within glomeruli; however, only high-dose ipragliflozin ameliorated the diabetes-induced up-regulation of Nox4 in glomeruli. The gene discussed is NOX4; the disease is diabetes mellitus.